国产综合一区二区三区,99香蕉国产精品偷在线观看,性色少妇AV蜜臀人妻无码,成版人app网站

您好,歡迎進(jìn)入上海力敏實(shí)業(yè)有限公司網(wǎng)站!
一鍵分享網(wǎng)站到:
您現(xiàn)在的位置:首頁(yè) >> 產(chǎn)品中心 >> 生化試劑、抗體、血清 >> 抗體/蛋白 >> santacruz SC-81805Talin-1 Antibody (YQ-16)

Talin-1 Antibody (YQ-16)

  • 更新時(shí)間:  2023-07-25
  • 產(chǎn)品型號(hào):  santacruz SC-81805
  • 簡(jiǎn)單描述
  • mouse monoclonal IgG3 provided at 100 µg/ml
    recommended for detection of Talin-1 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA
詳細(xì)介紹

SANTA CRUZ BIOTECHNOLOGY, INC.
Talin-1 (YQ-16): sc-81805
Santa Cruz Biotechnology, Inc. 1.800.457.3801 831.457.3800 831.457.3801 Europe +00800 4573 8000 49 6221 4503 0 www.scbt.com
BACKGROUND
Focal adhesions were identified as areas within the plasma membrane of
tissue culture cells that adhere tightly to the underlying substrate. In vivo,
these regions are involved in the adhesion of cells to the extracellular matrix.
Paxillin and vinculin are cytoskeletal, focal adhesion proteins that are components
of a protein complex that links the Actin network to the plasma
membrane. Vinculin binding sites have been identified on other cytoskeletal
proteins, including Talin-1 and α-actinin. In addition, vinculin, Talin-1, Talin-2
and α-actinin each contain Actin binding sites. Expression of vinculin, Talin-1
and Talin-2 have been shown to be affected by the level of Actin expression.
α-actinin has been shown to link Actin to integrins in the plasma membrane
through interactions with the vinculin and Talin complex or by a direct interaction
with integrin. Talin-2 is similar to Talin-1 but shows distinct patterns of
expression and cannot compensate for the loss of Talin-1.
REFERENCES
1. Burridge, K., et al. 1988. Focal adhesions: transmembrane junctions
between the extracellular matrix and the cytoskeleton. Annu. Rev. Cell
Biol. 4: 487-525.
2. Gilmore, A.P., et al. 1992. Further characterization of the Talin-binding site
in the cytoskeletal protein vinculin. J. Cell Sci. 103: 719-731.
3.Wood, C.K., et al. 1994. Characterisation of the paxillin-binding site and
the C-terminal focal adhesion targeting sequence in vinculin. J. Cell Sci.
107: 709-717.
4. Gluck, U., et al. 1994. Modulation of α-actinin levels affects cell motility
and confers tumorigenicity on 3T3 cells. J. Cell Sci. 107: 1773-1782.
5. Schevzov, G., et al. 1995. Impact of Actin gene expression on vinculin,
Talin, cell spreading, and motility. DNA Cell Biol. 14: 689-700.
6. Hemmings, L., et al. 1996. Talin contains three Actin-binding sites each of
which is adjacent to a vinculin-binding site. J. Cell Sci. 109: 2715-2726.
7. Gilmore, A.P., et al. 1996. Regulation of vinculin binding to Talin and Actin
by phosphatidyl-inositol-4-5-bisphosphate. Nature 381: 531-535.
CHROMOSOMAL LOCATION
Genetic locus: TLN1 (human) mapping to 9p13.3; Tln1 (mouse) mapping to
4 B1.
SOURCE
Talin-1 (YQ-16) is a mouse monoclonal antibody raised against recombinant
Talin-1 of human origin.
PRODUCT
Each vial contains 100 μg IgG3 in 1.0 ml PBS with < 0.1% sodium azide and
0.1% gelatin.
STORAGE
Store at 4° C, **DO NOT FREEZE**. Stable for one year from the date of
shipment. Non-hazardous. No MSDS required.
APPLICATIONS
Talin-1 (YQ-16) is recommended for detection of Talin-1 of mouse, rat and
human origin by Western Blotting (starting dilution 1:200, dilution range
1:100-1:1000), immunoprecipitation [1-2 μg per 100-500 μg of total protein
(1 ml of cell lysate)], immunofluorescence (starting dilution 1:50, dilution
range 1:50-1:500), immunohistochemistry (including paraffin-embedded
sections) (starting dilution 1:50, dilution range 1:50-1:500) and solid phase
ELISA (starting dilution 1:30, dilution range 1:30-1:3000).
Suitable for use as control antibody for Talin-1 siRNA (h): sc-36610, Talin-1
siRNA (m): sc-36611, Talin-1 shRNA Plasmid (h): sc-36610-SH, Talin-1 shRNA
Plasmid (m): sc-36611-SH, Talin-1 shRNA (h) Lentiviral Particles: sc-36610-V
and Talin-1 shRNA (m) Lentiviral Particles: sc-36611-V.
Molecular Weight of Talin-1: 230 kDa.
Positive Controls: RAW 264.7 whole cell lysate: sc-2211.
RECOMMENDED SECONDARY REAGENTS
To ensure optimal results, the following support (secondary) reagents are
recommended: 1) Western Blotting: use goat anti-mouse IgG-HRP: sc-2005
(dilution range: 1:2000-1:32,000) or Cruz Marker™ compatible goat antimouse
IgG-HRP: sc-2031 (dilution range: 1:2000-1:5000), Cruz Marker™
Molecular Weight Standards: sc-2035, TBS Blotto A Blocking Reagent:
sc-2333 and Western Blotting Luminol Reagent: sc-2048. 2) Immunoprecipitation:
use Protein A/G PLUS-Agarose: sc-2003 (0.5 ml agarose/2.0 ml).
3) Immunofluorescence: use goat anti-mouse IgG-FITC: sc-2010 (dilution
range: 1:100-1:400) or goat anti-mouse IgG-TR: sc-2781 (dilution range:
1:100-1:400) with UltraCruz™ Mounting Medium: sc-24941. 4) Immunohistochemistry:
use ImmunoCruz™: sc-2050 or ABC: sc-2017 mouse IgG
Staining Systems.
DATA
SELECT PRODUCT CITATIONS
1. Ah Kioon, M.D., et al. 2010. Adrenomedullin increases fibroblast-like synoviocyte
adhesion to extracellular matrix proteins by upregulating integrin
activation. Arthritis Res. Ther. 12: R190.
RESEARCH USE
For research use only, not for use in diagnostic procedures.

 

上海力敏實(shí)業(yè)有限公司代理santacruz產(chǎn)品,咨詢 
上海力敏實(shí)業(yè)有限公司代理santazruz產(chǎn)品,咨詢 


留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
久久人人爽人人爽人人片Ⅴ| 亚洲乳大丰满中文字幕| 高清a片在线观看| 被多个强壮的黑人灌满精| 精品国品一二三产品区别在线观看 | 无码少妇a片一区二区三区| 亚洲男同帅gay片在线观软件| 亚洲国产精品ⅤA在线观看| 欧美 亚洲 武侠 另类 动漫| 77777_亚洲午夜久久多人 | 极品少妇XXOO无码播放| 少妇脱了内裤让我添| 美国大片在线观看| 无码AV亚洲一区二区毛片| 婷婷亚洲五月色综合久久| 边做边爱mp3在线试听| 成人性做爰AAA片免费看曹查理| 肥大BBWBBW高潮喷水| 欧美最猛黑人xxxx黑人猛交| 久久精品国产99国产电影网| 337p粉嫩大胆色噜噜噜| 野花日本hd免费高清版1| 粗大猛烈进出高潮视频免费看| 无套内谢少妇毛片a片免费视频 | VR成人片在线播放网站| 日本三级欧美三级人妇视频| 70歳の熟女セックス合集| 亚洲一区二区三区女厕偷拍| 欧美激情综合五月色丁香| 老师好爽要尿了潮喷了视频高潮| 老公一到晚上就日不停| 亚洲日韩乱码人人爽人人澡人| 久久精品国产亚洲av不卡 | 国产美女裸体无遮挡免费视频| 无码日本精品xxxxxxxxx| 学长别揉了我快尿了男男| 亚洲欧美强伦一区二区| 高清毛片aaaaaaaaa片| 色婷婷av国产精品欧美毛片| 大杂乱小说目录阅读| 精品少妇ay一区二区三区|